Denver Biomedical

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Denver Biomedical - overview

Established

1969

Location

Golden, CO, US

Primary Industry

Medical Devices & Equipment

About

Based in Colorado, US, and founded in 1969, Denver Biomedical operates as a medical device and equipment company that specializes in the production, distribution, and promotion of fluid management devices for the chest and abdomen. Audax Group acquired Denver Biomedical in June 2004. In May 2006, Audax Group sold Denver Biomedical to Cardinal Health, Inc. Denver Biomedical specializes in the development, manufacture, and distribution of specialized medical devices for the treatment of fluid retention and pleural effusion in critical care.


Furthermore, the firm's product line includes both double-valved and single-valved shunting devices for effectively managing fluid retention. In addition, the company also produces a surgical access kit that allows for the safe and accurate insertion of both veins and abdominal urinary catheters.


Primary Industry

Medical Devices & Equipment

Sub Industries

Medical Equipment Distributors, Medical Supplies, Therapeutic Devices, Biomaterials

Website

www.denverbio.com

Verticals

HealthTech

Company Stage

Acquired

Total Amount Raised

Subscriber access only

Denver Biomedical - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
Trade SaleCompletedDenver Biomedical-
BuyoutCompletedDenver Biomedical-

Displaying 1 - 2 of 2

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.